CJC + Ipamorelin

Exceed Enhancement CJC-1295 + Ipamorelin blend is a research-grade injectable combination of CJC-1295 (a GHRH analog) and Ipamorelin (a ghrelin mimetic), designed for experimental studies on pulsatile growth hormone release, muscle anabolism, and recovery optimization in endocrine and performance models. This synergistic duo amplifies endogenous GH secretion without cortisol elevation, targeting IGF-1 pathways for body composition research.

Core Blend Benefits

• CJC-1295: Prolongs GH pulse duration via receptor binding, with studies showing sustained IGF-1 increases, enhanced protein synthesis, and fat metabolism in growth-deficient models.

• Ipamorelin: Selectively stimulates pituitary GH release through GHSR agonism, promoting lean mass gains, improved sleep architecture, and joint repair observed in recovery investigations.

For research purposes only. Not intended for human consumption.